Biología molecular del cáncer
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (24)
2024
-
Difficulties on the access to innovative targeted therapies for lung cancer in Spain
Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 597-612
-
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP
Clinical and Translational Oncology
2023
-
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine, Vol. 389, Núm. 6, pp. 504-513
-
Results in mediastinal lymph node staging of surgical lung cancer: Data from the prospective cohort of the Spanish Video-Assisted Thoracic Surgery Group
Cirugia Espanola, Vol. 101, Núm. 6, pp. 408-416
2022
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1
-
Impact of neoadjuvant therapy on postoperative complications in non-small-cell lung cancer patients subjected to anatomic lung resection
European Journal of Surgical Oncology, Vol. 48, Núm. 9, pp. 1947-1953
-
[Translated article] Surgical Risk Following Anatomic Lung Resection in Thoracic Surgery: A Prediction Model Derived From a Spanish Multicenter Database
Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. T398-T405
2021
-
Surgical Risk Following Anatomic Lung Resection in Thoracic Surgery: A Prediction Model Derived from a Spanish Multicenter Database
Archivos de Bronconeumologia
-
Targeted therapy moves to earlier stages of non-small-cell lung cancer: Emerging evidence, controversies and future challenges
Future Oncology, Vol. 17, Núm. 30, pp. 4011-4025
2020
-
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer
Clinical and Translational Oncology, Vol. 22, Núm. 1, pp. 21-36
-
Recommendations for acting in elective and urgent thoracic surgery during SARS-CoV-2 pandemic. Spanish Society of Thoracic Surgery
Cirugia Espanola, Vol. 98, Núm. 10, pp. 574-581
-
Spanish Video-Assisted Thoracic Surgery Group: Method, Auditing, and Initial Results From a National Prospective Cohort of Patients Receiving Anatomical Lung Resections
Archivos de Bronconeumologia, Vol. 56, Núm. 11, pp. 718-724
2018
-
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
European Journal of Cancer, Vol. 101, pp. 263-272
-
Hyperprogression as a distinct outcome after immunotherapy
Cancer Treatment Reviews, Vol. 70, pp. 16-21
2017
2015
-
BRCA1 Alternative splicing landscape in breast tissue samples
BMC Cancer, Vol. 15, Núm. 1
-
Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital polymerase chain reaction: Circulating-free DNA a powerful tool for biomarker testing in advance disease
Translational Research, Vol. 166, Núm. 6, pp. 783-787
2009
-
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients
Clinical and Translational Oncology, Vol. 11, Núm. 11, pp. 727-736
2007
-
Phase II study of trabectedin in pretreated patients with advanced colorectal cancer
Clinical Colorectal Cancer, Vol. 6, Núm. 7, pp. 522-528
-
Previous tumour as a prognostic factor in stage I non-small cell lung cancer
Thorax, Vol. 62, Núm. 5, pp. 386-390